9GKG | pdb_00009gkg

Crystal structure of UNC119 in complex with Squarunkin A


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.21 Å
  • R-Value Free: 
    0.257 (Depositor), 0.262 (DCC) 
  • R-Value Work: 
    0.222 (Depositor), 0.227 (DCC) 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history


Literature

UNC119 regulates T-cell receptor signalling in primary T cells and T acute lymphocytic leukaemia.

Samarakoon, Y.Yelland, T.Garcia-Gonzalez, E.da Silva Justo Junior, A.Mahmood, M.Manoharan, A.Patterson, S.Serafin, V.Gammage, P.A.Marmiroli, S.Halsey, C.Ismail, S.Roberts, E.W.

(2025) Life Sci Alliance 8

  • DOI: https://doi.org/10.26508/lsa.202403066
  • Primary Citation of Related Structures:  
    9GKG

  • PubMed Abstract: 

    T-cell receptor recognition of cognate peptide-MHC leads to the formation of signalling domains and the immunological synapse. Because of the close membrane apposition, there is rapid exclusion of CD45, and therefore LCK activation. Much less is known about whether spatial regulation of the intracellular face dictates LCK activity and TCR signal transduction. Moreover, as LCK is a driver in T acute lymphocytic leukaemia, it is important to understand its regulation. Here, we demonstrate a direct role of the ciliary protein UNC119 in trafficking LCK to the immunological synapse. Inhibiting UNC119 reduces localisation of LCK without impairing LCK phosphorylation and reduces T-cell receptor signal transduction. Although important for initial LCK reorganisation, activated CD8 + T cells retained their ability to kill target tumour cells when UNC119 was inhibited. UNC119 was also needed to sustain proliferation in patient-derived T-ALL cells. UNC119 may therefore represent a novel therapeutic target in T acute lymphocytic leukaemia, which alters the subcellular localisation of LCK in T acute lymphocytic leukaemia cells but preserves the function of existing cytotoxic lymphocytes.


  • Organizational Affiliation
    • CRUK Scotland Institute, Glasgow, UK youhani.samarakoon@cruk.cam.ac.uk.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Protein unc-119 homolog A182Homo sapiensMutation(s): 0 
Gene Names: UNC119RG4
UniProt & NIH Common Fund Data Resources
Find proteins for Q13432 (Homo sapiens)
Explore Q13432 
Go to UniProtKB:  Q13432
PHAROS:  Q13432
GTEx:  ENSG00000109103 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ13432
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.21 Å
  • R-Value Free:  0.257 (Depositor), 0.262 (DCC) 
  • R-Value Work:  0.222 (Depositor), 0.227 (DCC) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 78.73α = 90
b = 80.63β = 90
c = 191.03γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
xia2data reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Cancer Research UKUnited Kingdom--

Revision History  (Full details and data files)

  • Version 1.0: 2025-01-15
    Type: Initial release
  • Version 1.1: 2026-01-28
    Changes: Database references, Other